Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Prostate Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00879619
What this trial is testing

Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer+3 more
John P. Fruehauf 4
Not applicableActive Not RecruitingNCT00967863
What this trial is testing

Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)

Who this might be right for
Prostate Cancer
UNICANCER 500
Testing effectiveness (Phase 2)Study completedNCT00017563
What this trial is testing

Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 57
Large-scale testing (Phase 3)Active Not RecruitingNCT03070886
What this trial is testing

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

Who this might be right for
Stage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7Stage III Prostate Adenocarcinoma AJCC v7
NRG Oncology 612
Not applicableActive Not RecruitingNCT04384770
What this trial is testing

CT-guided Stereotactic Body Radiation Therapy and MRI-guided Stereotactic Body Radiation Therapy for Prostate Cancer, MIRAGE Study

Who this might be right for
Prostate Adenocarcinoma
Jonsson Comprehensive Cancer Center 179
Early research (Phase 1)Study completedNCT00026377
What this trial is testing

SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Chicago 3
Large-scale testing (Phase 3)Active Not RecruitingNCT06205316
What this trial is testing

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Who this might be right for
Biochemically Recurrent Prostate CarcinomaOligometastatic Prostate CarcinomaRecurrent Prostate Adenocarcinoma+4 more
Mayo Clinic 118
Large-scale testing (Phase 3)WithdrawnNCT02053311
What this trial is testing

Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents

Who this might be right for
Prostate Cancer
Swiss Cancer Institute
Early research (Phase 1)Ended earlyNCT00023634
What this trial is testing

S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer

Who this might be right for
Brain TumorsGastric CancerOvarian Cancer+1 more
SWOG Cancer Research Network 14
Testing effectiveness (Phase 2)WithdrawnNCT01079793
What this trial is testing

Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center
Very early researchStudy completedNCT02646319
What this trial is testing

Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations

Who this might be right for
Advanced Malignant NeoplasmCervical Squamous Cell CarcinomaEndometrial Carcinoma+29 more
Mayo Clinic 2
Large-scale testing (Phase 3)UnknownNCT00003734
What this trial is testing

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
St. Luke's Hospital, Ireland 276
Early research (Phase 1)Study completedNCT00096629
What this trial is testing

Vaccine Therapy in Treating Patients With Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center 15
Not applicableStudy completedNCT01664130
What this trial is testing

High-Dose Stereotactic Radiation for Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
Case Comprehensive Cancer Center 35
Testing effectiveness (Phase 2)Ended earlyNCT01703065
What this trial is testing

Cabozantinib in Men With Castration-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateCastration-resistant Prostate CancerRecurrent Prostate Cancer+2 more
University of Washington 9
Testing effectiveness (Phase 2)Study completedNCT00091390
What this trial is testing

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 129
Testing effectiveness (Phase 2)Study completedNCT02849990
What this trial is testing

A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy

Who this might be right for
Stage III Prostate Adenocarcinoma AJCC v7Stage III Prostate Cancer AJCC v7Stage IV Prostate Adenocarcinoma AJCC v7+1 more
University of Washington 22
Not applicableActive Not RecruitingNCT00860652
What this trial is testing

Radiotherapy - Adjuvant Versus Early Salvage

Who this might be right for
Prostate Cancer
Trans Tasman Radiation Oncology Group 333
Large-scale testing (Phase 3)Active Not RecruitingNCT05050084
What this trial is testing

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Who this might be right for
Prostate Adenocarcinoma
NRG Oncology 2,050
Large-scale testing (Phase 3)Looking for participantsNCT01492972
What this trial is testing

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Proton Collaborative Group 192
Next Page